ARCHIVES

House Approves 1.9 Percent Increase For NIH.

This article is from The Cancer Letter archive.

Vol. 33 No. 28 | July 20, 2007

Download PDF Visit The Full Archive

Related Articles

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

March 17, 1995

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

Robert Day Named New Director At Hutchinson Center

June 19, 1981

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001